Cite
HARVARD Citation
Masana, L. et al. (2019). Evolocumab Is Mainly Prescribed In Fh Patients With/Without Atherosclerotic Cardiovascular Disease (Ascvd) In Lipid/Internal Medicine Units In Spain: A Retrospective, Observational Study (Retoss-Imu). Atherosclerosis. pp. e198-. [Online].